3.0.0 1941 2026-07-21T15:43:42Z 2026-07-21T15:43:42Z Senate S S 2025-06-04 119 https://www.congress.gov/bill/119th-congress/senate-bill/1941 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred To 2025-06-04T17:24:47Z Cure Hepatitis C Act of 2026 119 9682 HR 2026-07-14 Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Related bill CRS 2025-06-04 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2025-06-04 Introduced in Senate IntroReferral 10000 9 Library of Congress C001075 Sen. Cassidy, Bill [R-LA] Bill Cassidy R LA N V000128 Sen. Van Hollen, Chris [D-MD] Chris Van Hollen D MD 2025-06-04 True Health Health 2025-06-25T12:47:17Z 00 2025-06-04 Introduced in Senate 2026-05-27T20:37:27Z Cure Hepatitis C Act of 2025

This bill establishes programs and requirements to provide free medications to treat hepatitis C in certain high-risk or vulnerable populations. It also establishes grants and other resources to support testing and treatment for hepatitis C. The bill provides funding for FY2025 to implement these provisions.

The Department of Health and Human Services (HHS) must enter into a five-year purchasing contract with manufacturers of drugs that treat hepatitis C so that eligible individuals may receive the drugs without cost-sharing. Eligible individuals are those diagnosed with hepatitis C who are (1) enrolled in Medicaid or the Children’s Health Insurance Program (CHIP), (2) confined to federal, state, or local correctional facilities (or were released and began treatment there), (3) uninsured, or (4) receiving health care through the Indian Health Service.

Eligibility is limited to those with specified legal immigration statuses. State Medicaid and CHIP programs and state and local correctional facilities may opt into the program; participation is mandatory for federal correctional facilities and the Indian Health Service. 

HHS must award grants to certain entities, including states, public health organizations, and correctional facilities, to support the coordination and provision of screening, treatment, and supportive services for the affected populations. 

The bill also allows Medicare beneficiaries to receive hepatitis C drugs without cost-sharing from 2027-2031.

]]> Cure Hepatitis C Act of 2025 Display Title 45 Cure Hepatitis C Act of 2025 2025-06-12T05:38:18Z Short Title(s) as Introduced 101 Cure Hepatitis C Act of 2025 2025-06-12T05:38:16Z Introduced in Senate IS Official Title as Introduced 6 A bill to require the Secretary of Health and Human Services to carry out activities to eliminate hepatitis C virus in the United States. 2025-06-12T05:33:18Z Introduced in Senate IS Introduced in Senate 2025-06-04T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-119s1941is/xml/BILLS-119s1941is.xml 2025-06-04 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.